Moyamoya Disease Differential Diagnoses
- Author: Roy Sucholeiki, MD; Chief Editor: Amy Kao, MD more...
Diagnostic Considerations
Conditions to consider in the differential diagnosis of moyamoya disease include the following:
- Homocystinuria/homocysteinemia
- Hyperglycemia/hypoglycemia
- Syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS)
- Methylmalonic acidemia
- Propionic acidemia
- Neurofibromatosis, type 1
- Neurofibromatosis, type 2
- Pituitary tumors
- Polyarteritis nodosa
- Posterior cerebral artery stroke
- Subarachnoid hemorrhage
- Temporal/giant cell arteritis
- Tolosa-Hunt syndrome
- Apert syndrome
- Aplastic anemia
- Brainstem syndromes
- Cranial trauma
- Coarctation of the aorta
- Fanconi anemia
- Irradiation injury
- Leptospirosis
- Marfan syndrome
- Mitochondrial cytopathies
- Parasellar tumors
- Sickle cell disease
- Tuberculosis
- Turner syndrome
- Vasculitis
- Carotid disease and stroke
Differential Diagnoses
- Anterior Circulation Stroke
- Basilar Artery Thrombosis
- Blood Dyscrasias and Stroke
- Cavernous Sinus Syndromes
- Cerebral Aneurysms
- Craniopharyngioma
- Dissection Syndromes
- Fabry Disease
- Fibromuscular Dysplasia
- Intracranial Hemorrhage
Janda PH, Bellew JG, Veerappan V. Moyamoya disease: case report and literature review. J Am Osteopath Assoc. Oct 2009;109(10):547-53. [Medline].
Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. Sep 2006;77(9):1025-9. [Medline].
Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. Jun 10 2008;70(24 Pt 2):2357-63. [Medline].
Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke. Jan 2010;41(1):173-6. [Medline].
Im SH, Oh CW, Kwon OK, et al. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. J Neurosurg. Jun 2005;102(6):1013-7. [Medline].
Uchino K, Johnson A, Claiborne S, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65:956-958. [Medline].
Li H, Zhang ZS, Dong ZN, et al. Increased Thyroid Function and Elevated Thyroid Autoantibodies in Pediatric Patients With Moyamoya Disease: A Case-Control Study. Stroke. Feb 24 2011;[Medline].
Starke RM, Komotar RJ, Hickman ZL, et al. Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg. Nov 2009;111(5):936-42. [Medline].
Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. May 2005;21(5):358-64. [Medline].
Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. Feb 2004;100(2 Suppl Pediatrics):142-9. [Medline].
Hoffman HJ. Moyamoya disease and syndrome. Clin Neurol Neurosurg. Oct 1997;99 Suppl 2:S39-44. [Medline].
Cohen N, Berant M, Simon J. Moyamoya and Fanconi's anemia. Pediatrics. Apr 1980;65(4):804-5. [Medline].
Gosalakkal JA. Moyamoya disease: a review. Neurol India. Mar 2002;50(1):6-10. [Medline].

